A program to help rural smokers who aren't ready to quit

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests a novel implementation program aimed at increasing access to tobacco control services for rural adults who smoke but are not yet ready to quit. It employs a hybrid approach that combines implementation and effectiveness outcomes, utilizing community paramedicine and mobile health technology. The trial will compare a standard implementation program with an enhanced version that includes an EMS Champion program, focusing on counties with high smoking rates in rural areas. Participants will receive support through a mobile health-assisted brief abstinence experience alongside nicotine replacement therapy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Current Smoker
* at least 18 years old
* speaks English
* Able to receive texts and read text (literate)
* Have a text-enabled phone or receive one from the study team
* Not yet ready to quit smoking

Exclusion Criteria:

* actively quitting smoking
* preparing to quit smoking within 30 days
* prisoners
* FDA- defined NRT contraindications
* unable or unwilling to provide informed consent

Where it's running

• Wake Forest University Health Sciences
  Winston-Salem, North Carolina, United States Recruiting

Study contacts

• Principal investigator: Thomas K Houston, MD, MPH — Wake Forest University Health Sciences
• Study coordinator: Anna M Thorpe
• Email: Anna.Thorpe@advocatehealth.org
• Phone: 336-716-3028

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using an air quality monitor to encourage smoke-free homes for cancer patients

  This study is testing if using an air quality monitor can help cancer patients who smoke create smoke-free homes and quit smoking.

  Recruiting at 7 sites Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 7 other locations · NCT06693700

• Tirzepatide for Smoking Cessation in people who smoke and are overweight or obese

  This study tests whether tirzepatide can help adults who smoke quit and manage weight better than placebo when combined with usual smoking-cessation support.

  Recruiting at 4 sites Phase 2 University of Southern California · Los Angeles, California and 3 other locations · NCT07602699

• Personalized treatment to help people with cancer quit smoking and live longer

  We will test whether personalized tobacco treatment using clinical, genetic, and biomarker information helps cancer patients who smoke quit and use cessation medications more than usual care.

  Recruiting at 2 sites Washington University School of Medicine · St Louis, Missouri and 1 other locations · NCT07166120

• Abuse potential of five modern oral nicotine products

  This will test how five modern oral nicotine products compare with cigarettes and nicotine gum in how satisfying they feel and how much nicotine adult smokers absorb.

  Recruiting RAI Services Company · Overland Park, Kansas · NCT07132814

• ACT Lung Health Program to help Chinese and Korean American smokers quit

  This trial tests a counseling and educational program to help Chinese and Korean American smokers at high risk for lung cancer quit smoking.

  Recruiting at 2 sites Dana-Farber Cancer Institute · Boston, Massachusetts and 1 other locations · NCT06945120

• Actívatexto: Helping Latinos quit smoking and become more active

  This trial tests whether Actívatexto, a text-message program combined with wearables and nicotine replacement, helps Latino adults who smoke quit and increase their physical activity.

  Recruiting University of Rochester · Rochester, New York · NCT06926608

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.